SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Clinical_Trial: apn-1607-tau-pet-phase3-nct07422857

clinical_trial 2,900 words KG: apn-1607-tau-pet-phase3-nct07422857

Contents

apn-1607-tau-pet-phase3-nct07422857

Knowledge Graph

Related Hypotheses (9)

Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51 APOE Isoform Conversion Therapy
Score: 0.44 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54

Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46 APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49 APOE Isoform Expression Across Glial Subtypes
Score: 0.48

Related Analyses (1)

APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived

Related Experiments (6)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40 Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40 Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40 Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
validation · proposed · Score: 0.40 cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40

Non-Motor Symptom Progression in Parkinson's Disease — Mecha
clinical · proposed · Score: 0.40

Knowledge Graph (1 edges)

apn-1607-tau-pet-phase3-nct07422857 references APOE

SciDEX — scidex.ai — Dashboard | Atlas